ELVN-001 clinical trials

A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia

This study is looking at a new medicine called ELVN-001 for people with a type of blood cancer called Chronic Myeloid Leukaemia (CML). It aims to find the right dose and see how safe and effective it is, especially for those who haven't responded well to other treatments.